81 related articles for article (PubMed ID: 8334261)
21. Continuous wave Doppler measurements of aortic bloodflow during exercise in patients with chronic heart failure.
Arnold JM; Cheung P; Burton GL
Can J Cardiol; 1994 Mar; 10(2):185-92. PubMed ID: 8143219
[TBL] [Abstract][Full Text] [Related]
22. [The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium].
Schindler R; Krahe T; Neubauer S; Hillenbrand H; Entzeroth C; Horn M; Lackner K; Ertl G
Rofo; 1992 Nov; 157(5):452-7. PubMed ID: 1421185
[TBL] [Abstract][Full Text] [Related]
23. Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy.
Jung WI; Sieverding L; Breuer J; Schmidt O; Widmaier S; Bunse M; van Erckelens F; Apitz J; Dietze GJ; Lutz O
J Magn Reson; 1998 Jul; 133(1):232-5. PubMed ID: 9654494
[TBL] [Abstract][Full Text] [Related]
24. Congestive heart failure complicating aortic regurgitation with medical and surgical management: a prospective study of traditional and quantitative echocardiographic markers.
Detaint D; Maalouf J; Tribouilloy C; Mahoney DW; Schaff HV; Tajik AJ; Enriquez-Sarano M
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1549-57. PubMed ID: 19114205
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis of myocardial ischemia and viability by 31P nuclear magnetic resonance spectroscopy].
Mitsunami K; Yabe T; Kinoshita M
Rinsho Byori; 1998 Apr; 46(4):348-53. PubMed ID: 9594625
[TBL] [Abstract][Full Text] [Related]
26. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of transient apical ballooning with cardiac magnetic resonance imaging and 31-phosphorous magnetic resonance spectroscopy.
Klug G; Wolf C; Trieb T; Frick M; Koehler A; Schocke MF; Jaschke W; Pachinger O; Metzler B
Int J Cardiol; 2007 May; 118(2):249-52. PubMed ID: 17049390
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
[TBL] [Abstract][Full Text] [Related]
29. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
[TBL] [Abstract][Full Text] [Related]
30. 31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging.
Sakuma H; Takeda K; Tagami T; Nakagawa T; Okamoto S; Konishi T; Nakano T
Am Heart J; 1993 May; 125(5 Pt 1):1323-8. PubMed ID: 8480584
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
[TBL] [Abstract][Full Text] [Related]
32. [The 31-phosphorus spectroscopy of space-occupying lesions of the salivary glands. The clinical results and differential diagnosis].
Vogl TJ; Dadashi A; Jassoy A; Becker C; Reimann V; Lissner J
Rofo; 1993 Jan; 158(1):31-8. PubMed ID: 8425072
[TBL] [Abstract][Full Text] [Related]
33. Cardiac magnetic resonance spectroscopy: potential clinical applications.
Neubauer S
Herz; 2000 Jun; 25(4):452-60. PubMed ID: 10948781
[TBL] [Abstract][Full Text] [Related]
34. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.
Conway MA; Allis J; Ouwerkerk R; Niioka T; Rajagopalan B; Radda GK
Lancet; 1991 Oct; 338(8773):973-6. PubMed ID: 1681342
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging and spectroscopy of the heart.
de Roos A; van der Wall EE
Curr Opin Cardiol; 1991 Dec; 6(6):946-52. PubMed ID: 10149602
[TBL] [Abstract][Full Text] [Related]
36. Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy.
Nakae I; Mitsunami K; Matsuo S; Inubushi T; Morikawa S; Tsutamoto T; Koh T; Horie M
Circ J; 2005 Jun; 69(6):711-6. PubMed ID: 15914951
[TBL] [Abstract][Full Text] [Related]
37. Is MR spectroscopy of the heart ready for humans?
Holloway C; Clarke K
Heart Lung Circ; 2010 Mar; 19(3):154-60. PubMed ID: 20185367
[TBL] [Abstract][Full Text] [Related]
38. Methodological advances in cardiac 31P-MR spectroscopy.
von Kienlin M
MAGMA; 2000 Nov; 11(1-2):36-8. PubMed ID: 11186980
[No Abstract] [Full Text] [Related]
39. Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure.
Qureshi WT; Nasir UB
Heart Fail Rev; 2017 Jul; 22(4):491-499. PubMed ID: 28386690
[TBL] [Abstract][Full Text] [Related]
40. [Clinical relevance of MR spectroscopy of the heart].
Neubauer S
Z Kardiol; 2000; 89 Suppl 1():74-7. PubMed ID: 10907304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
